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Hybrid and Composite Scaffolds Based on Extracellular
Matrices for Cartilage Tissue Engineering
Mohsen Setayeshmehr, MS,1–3 Ebrahim Esfandiari, MD, PhD,4 Mohammad Rafieinia, PhD,2
Batool Hashemibeni, PhD,4 Asghar Taheri-Kafrani, PhD,5 Ali Samadikuchaksaraei, MD, PhD,1,6
David L. Kaplan, PhD,7 Lorenzo Moroni, PhD,3,8 and Mohammad T. Joghataei, PhD1,6
Cartilage consists of chondrocytes and a special extracellular matrix (ECM) having unique biochemical, bio-
physical, and biomechanical properties that play a critical role in the proliferation and differentiation of cells
inherent to cartilage functions. Cartilage tissue engineering (CTE) requires recreating these microenvironmental
physicochemical conditions to lead to chondrocyte differentiation from stem cells. ECM-derived hybrid scaf-
folds based on chondroitin sulfate, hyaluronic acid, collagen, and cartilage ECM analogs provide environments
conducive to stem cell proliferation. In this review, we describe hybrid scaffolds based on these four cartilage
ECM derivatives; we also categorize these scaffolds based on the methods used for their preparation. The use of
hybrid scaffolds is increasing in CTE to address the complexity of cartilage tissue. Thus, a comprehensive
review on the topic should be a useful guide for future research.
Keywords: cartilage, tissue engineering, hybrid scaffolds, extracellular matrix (ECM), ECM derivatives
Impact Statement
Scaffolds fabricated from extracellular matrix (ECM) derivatives are composed of conducive structures for cell attachment,
proliferation, and differentiation, but generally do not have proper mechanical properties and load-bearing capacity. In
contrast, scaffolds based on synthetic biomaterials demonstrate appropriate mechanical strength, but the absence of de-
sirable biological properties is one of their main disadvantages. To integrate mechanical strength and biological cues, these
ECM derivatives can be conjugated with synthetic biomaterials. Hence, hybrid scaffolds comprising both advantages of
synthetic polymers and ECM derivatives can be considered a robust vehicle for tissue engineering applications.
Introduction
Articular cartilage (AC) is a connective tissuecomprising also the main component of joints’ surface,
which covers and protects bones. Cartilage is composed
of specialized cells and extracellular matrix (ECM).1 Three
major types of cartilaginous tissues are distinguished:
hyaline cartilage, fibrocartilage, and elastic cartilage. The
chemistry and the supramolecular structure of the matrices
determine the biomechanical and functional properties of
these three cartilage types. Hyaline cartilage is the most
abundant and well characterized, found as AC on the sur-
faces of bones.2,3 AC can bear loads of up to around 20 MPa
during normal joint movements.1 The major macromolecular
components of hyaline cartilage include collagen (COL) type II
and X, cartilage oligomeric matrix protein, and proteoglycans,
1Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of
Medical Sciences (IUMS), Tehran, Iran.
2Biomaterials Nanotechnology and Tissue Engineering Group, Department of Advanced Medical Technology, Isfahan University of
Medical Sciences, Isfahan, Iran.
3MERLN Institute for Technology Inspired Regenerative Medicine, Complex Tissue Regeneration, Maastricht University, Maastricht,
The Netherlands.
4Department of Anatomical Sciences and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
5Department of Biotechnology, Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.
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among which aggrecan (ACAN) is the major component. Col-
lagens and proteoglycans play critical roles in maintaining
cartilage ECM structure. The mechanical strength of the dif-
ferent zones of AC is defined by changes in chemistry and
biomechanical cues of the macromolecular components.3–5
Mechanical characteristics and load-bearing ability of AC are
related to and optimized by the arrangement of COL fiber or-
ganization, proteoglycan content, and chondrocyte shape.6 The
ECM also forms a niche for stem cells (SCs) and provides
biochemical and physical signals to control their proliferation.7
Recent studies demonstrated that SCs necessitate a particular
tissue niche for proliferation and differentiation.8 In addition to
the biochemical environment, mechanical cues of the ECM,
such as stiffness, also impact SC lineage differentiation.9 Soft,
medium, and hard matrices can induce mesenchymal stromal
cells (MSCs) to differentiate into neurons, myocytes, and os-
teoblasts, respectively.10 MSCs are site regulated; they secrete
different factors to modulate tissue protection and regeneration
by interacting with their niche microenvironment mediated by
ECM components.11
Recent studies demonstrate that chondrocytes sense phys-
ical cues such as receptor/ligand density, rigidity/softness,
and shape (dimensionality) of the ECM surface by mech-
anoreceptors. In response to these cues, the cells modulate
the organization of the cytoskeleton, extracellular adhesion
sites, and cell shape.12,13 Studies performed on artificial
scaffolds, such as hydrogels, porous/fibrous scaffolds, and
ECM-based constructs, demonstrated that SCs expand and
differentiate, faster on the softer materials such as COL
than stiffer substrates such as chitosan (CHSN).14,15 One
approach to create three-dimensional (3D) structures that
mimic the cartilage natural niche is to utilize scaffolds
based on cartilage ECM, but generally these scaffolds have
lower mechanical strength and suffer from lot-to-lot vari-
ations.16 Synthetic and polymeric materials, including
poly(DL-lactic-co-glycolic acid) (PLGA), poly(e-caprolactone)
(PCL), poly(D,L-lactic acid) (PLA) and their copolymers,
poly vinyl alcohol (PVA) and also methacrylamide (MA)
modification, have been used to fabricate scaffolds for AC
replacement and to serve as cell transplantation vehicle for
tissue engineering (TE).17–20 Synthetic polymeric scaffolds
allow for good control of mechanical properties, but suffer
from a lack of biological properties. These biomaterials are
hydrophobic, lack functional adhesion sites and cell rec-
ognition signals, and therefore must be modified before
cell seeding.21 In contrast, scaffolds manufactured from
ECM components contain surface structures conducive to
cell growth.22 Hence, hybrid scaffolds comprising both
advantages of synthetic polymers and ECM derivatives can
be considered a strong vehicle for TE applications.23
Although other reviews related to cartilage ECM de-
rivatives have been published already, this review focuses
on cartilage ECM-derived hybrid and composite scaffolds,
prepared and used specifically for cartilage tissue engi-
neering (CTE). Four sections describe (1) COL and COL-
based scaffolds, (2) hyaluronic acid (HA) and HA-based
scaffolds, (3) chondroitin sulfate (CS) and CS-based
scaffolds, and (4) cartilage ECM analogs (cECMa) and
cECMa-based scaffolds. The fifth section reviews the
different hybrid scaffold processing approaches, and in the
sixth section, results from ECM-based scaffolds are dis-
cussed in detail.
Hybrid and Composite Scaffolds for CTE
COL-based scaffolds
Collagens can be considered the most important proteins
of connective tissue in mammals and also the most abundant
proteins in their body.24 About 30 different forms of COL
have been defined according to the amino acid sequences
and the structures that they are arranged into. The three most
common types of collagens are type II, type I, and type X,
in hyaline cartilage, fibrocartilage, and hypertrophic carti-
lage, respectively.25 As abundant and biocompatible natural
products, collagens have been thoroughly investigated and
are widely used as TE scaffolds.26 Important drawbacks of
collagens are, however, inferior mechanical strength and
quick degradation, compromising their use for CTE appli-
cations. These disadvantages can be partially rectified by
crosslinking27 collagens with natural and synthetic polymers
to afford blends and composite materials of superior prop-
erties.28 For instance, blend scaffolds composed of COL
crosslinked with CHSN have improved mechanical strength
than unmodified COL.29 A mixture of COL and CHSN
exhibits higher mechanical strength because of their misci-
bility, hydrogen bonding, and electrostatic interactions that
reinforce the composite.30 Partial hydrolysis of COL leads
to gelatin (GEL) production. Despite its similarity to chemical
COL composition, it lacks antigenicity and immunogenicity.
GEL has been used for cartilage, bone, and nerve TE.31 Hybrid
scaffolds composed of COL and synthetic materials, such as
PLA, PLGA, PVA, PCL, MA, poly(ethylene glycol) (PEG), or
natural biomaterials, including CHSN, agarose (AGR), algi-
nate (ALG), elastin, silk fibroin (SF), and others that have been
used for CTE, are listed in Table 1.
HA-based scaffolds
Hyaluronic acid (HA) is a key component in the ECM of
cartilage. It is an anionic glycosaminoglycan (GAG) of up to
4000 kDa with hydrogel-like properties.63,77–80 Elasticity
and viscosity of the synovial fluid and shock absorbance
capacity in articular joints are due to HA. HA is the pri-
mary ligand of the CD44 receptor, and several functions of
the CD44 receptor are mediated through interaction with
HA.81,82 Crosslinking is the most common modification of
HA, to form hydrogels for TE applications. The methacry-
lation is one of the frequently used technique for modification
of HA hydrogels. Changing the methacrylation percentage
directly effects on the crosslinking density and stiffness of the
hydrogel matrix.83 HA has also been chemically functiona-
lized for the attachment of reporter groups for drug delivery
systems. Composite materials of HA with natural and syn-
thetic polymers were developed into biomimetic scaffolds
with ability of enhancing wound healing and angiogenesis.84
Hybrid and composite scaffolds composed of HA and syn-
thetic materials (PLGA, PVA, PEG, and MA) and with nat-
ural biomaterials (CHSN, fibrin, AGR, ALG, and dextran)
have been used for CTE (Table 2).
CS-based scaffolds
CS is a GAG, a long unbranched and polar polysaccharide
consisting of amino sugars and sugar acids. CS plays a
critical role as a main component of the ECM in cartilage
functions.125 The ECM regulates metabolism as well as
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gene expression and stimulates proliferation and differenti-
ation of chondrocytes.126 The biological activities of CS
make it an ideal biomaterial for CTE. The chondroprotective
action of CS can be explained by the stimulation of the
anabolic progression of cartilage metabolism, and its anti-
inflammatory action, delaying numerous inflammation-
induced catabolic processes in the tissue.127,128 The inclu-
sion of CS in composite scaffolds improves their mechanical
properties and compressive strength by interacting with cell
surface receptors to regulate chondrocyte behavior.129 Hy-
brid scaffolds containing CS and synthetic as well as natural
polymers have been used for CTE and are listed in Table 3.
ECM analog-based scaffolds
The use of decellularized ECM scaffolds and tissues
is speedily expanding in TE.146 There are many reasons
for utilization of ECM-based materials in TE applications,
including promotion of SC recruitment, cell infiltration,
and differentiation without the need of additional bio-
logical factors. Cartilaginous ECM may be innovative
in orthopedic medicine because of its chondroinductive
potential, particularly in hydrogel-based systems.147 The
potential of ECM-based scaffolds to retain growth factors
such as transforming growth factor-beta 1 (TGF-b1), fi-
broblast growth factor, and insulin-like growth factor is
one of the major advantages of utilizing these materials as
a scaffold.148 However, the inferior mechanical properties
of scaffolds composed completely of natural materials com-
pared with synthetic materials are a major disadvantage for
load-bearing tissue applications. Therefore, combinations of
these ECM-based materials with suitable synthetic materials
can be of advantage for CTE.147 Hybrid scaffolds composed
of ECM analogs and synthetic materials, as well as nat-
ural biomaterials, have been used for CTE and are listed
in Table 4.
Hybrid Scaffold Processing Approaches
A multitude of porous ECM-derived hybrid scaffolds and
scaffold processing approaches have been utilized in CTE.
The most frequently used types are discussed below.
Fibrous scaffolds
Electrospinning of natural and synthetic biomaterials is a
promising technique to produce fibrous scaffolds for TE
applications.102 The combination of synthetic polymeric
materials and natural components such as COL could in-
crease cell attachment while presenting ideal mechanical
properties for TE applications.56 PCL–COL electrospun
meshes were used in autologous chondrocyte implantation
as an innovative substitute to conventional grafts, which was
the first try to design a mechanically enhanced cartilage
resurfacing membrane composed of strong PCL mesh with
bioactive COL. MSCs adhered on the surface of the mesh
after seeding. More importantly, the mesh induced MSC
differentiation into chondrocytes and inhibited a cellular
hypertrophic response. This study showed the impact of the
use of PCL–COL hybrid mesh as a cartilage patch and
showed the importance of incorporation of the ECM-derived
component COL into the synthetic PCL.163 In a similar
study, oriented PLA-co-PCL/COL I nanofiber yarn meshes
were fabricated by dynamic liquid electrospinning and aided
as a skeleton for a freeze-dried (FD) COL I/HA chondral
phase to improve the mechanical properties of the scaffolds.
In vitro and in vivo results demonstrated that the hybrid
constructs allowed cell infiltration similar to sponge scaf-
folds, and repaired the rabbit model osteochondral defects
with improved mechanical properties of the newly engineered
cartilage.57 In another approach, COL/PVA nanofiber scaf-
folds were prepared and seeded with autologous MSCs to
repair osteochondral defects of rabbit joints. The hybrid
scaffolds induced higher chondrocyte morphology and new
cartilage formation compared with the control defect without
any treatment. The results showed that the nanofibrous COL/
PVA scaffolds provide a supportive environment for cartilage
tissue (CT) regeneration over 12 weeks. The histological
results demonstrated that the COL/PVA group had better
cartilage repair, more new matrix formation, and continuous
subchondral bone compared with the control group.66 In a
further approach, oriented PCL fibers were fabricated by
melt electrospinning writing (MEW) and combined with
gelatin-methacrylamide (GEL-MA) and GEL-MA/HA-MA
hydrogels to produce fiber-reinforced GEL-MA/HA-MA
composites with enhanced mechanical properties. The re-
sults demonstrate that reinforcement of hydrogels with fi-
bers leads to increases in the mechanical properties of the
hybrid construct.55 In vitro and in vivo studies on a sand-
wich model of electrospun GEL/PCL membranes, seeded
with MSC/chondrocyte cocultures, were performed. To en-
gineer the sandwich model, a GEL/PCL mesh was placed at
the bottom of a well and seeded with cell suspension. A
second mesh was then stacked on top of the first sheet, fol-
lowed by cell seeding. The stacking was repeated until ten
sheets. After implantation of the sandwich constructs 12
weeks subcutaneously into nude mice, histological analysis,
GAG assay, and mechanical property measurement con-
firmed the formation of mature cartilage-like tissue. The
strategy indicated that designed constructs were suitable for
SC-based CTE. The constructs showed white appearance,
flexibility, and a well-distributed synthesized neomatrix typ-
ical of cartilage.56
Yamane et al.164 developed hybrid fibers based on CHSN
and CHSN-HA by wet spinning. Articular chondrocytes
from rabbits were cultured in the sheets of CHSN- and HA-
based hybrid fibers. The fibers exhibited potential as an
appropriate biomaterial for cartilaginous tissue scaffolds.124
In a similar study, 3D scaffolds based on novel CHSN-based
HA hybrid polymer fibers, which could control porous
structure, were fabricated by wet spinning. The results
showed that cell adhesion, proliferation, and synthesis of
ACAN were higher in the CHSN-HA hybrid fiber than in
the CHSN-only group.164
Chondroinductive nanofiber composites of PVA-MA and
chondroitin sulfate-methacrylamide (CS-MA) were synthe-
sized and used for AC repair. MSCs cultured on these
scaffolds were shown to support an increase in cell prolif-
eration, ECM production, and cartilage-specific gene ex-
pression (Fig. 1) in vitro as well as in vivo.165
ECM-coated scaffolds display the advantages of both nat-
ural and synthetic components. Polymeric scaffolds provide
the strength and robustness to support tissue growth, while
the ECM coating acts in bioactive signal providing needed
cues for differentiation.160 Electrospun PCL microfibers
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were coated with cartilaginous ECM to fabricate PCL/
ECM composite scaffolds. Briefly, chondrocytes were
cultured in a flow perfusion bioreactor, and then, the
cellular constructs were decellularized. The composite
scaffolds in the presence of TGF-b1 exposure showed
upregulation of ACAN and COL II gene expression.161 In
a similar approach, coculture of chondrocytes and MSCs
on electrospun fibrous scaffolds was performed to produce
polymer/ECM hybrid constructs. The results indicated the
capacity of cocultures to deposit cartilaginous matrix
within a polymeric scaffold. Thus, cocultures of MSCs
and chondrocytes can be used to reduce the needed
chondrocytes to fabricate polymer/ECM hybrid scaf-
folds.160 An innovative technique was performed to fab-
ricate PCL and PCL/cartilage-derived matrix scaffolds by
the serial collection of 60 electrospun single-layer scaf-
folds, which were then seeded with human adipose-
derived stem cells (hADSCs). The results indicated that
multilayer hybrid constructs improved homogeneous cell
seeding and showed chondrogenesis-related bioactivity.159
Recent studies demonstrated that electrospinning can pro-
duce fibrous scaffolds with a high surface/volume ratio,
resembling the natural ECM pore structure, thus useful in
terms of cell adhesion, proliferation, and differentiation. To
improve cell–scaffold interactions, a range of natural and
synthetic biomaterials can be blended into the fibrous scaf-
folds. In view of the fact that the biodegradation rate of
scaffolds can influence cell behavior and the following tissue
regeneration, a proper biodegradation rate of the hybrid me-
shes can also be produced to match and control the rate of
tissue regeneration.
Hydrogel scaffolds
Hydrogels are composed of hydrophilic polymer chains
with natural or synthetic origin. They offer many advan-
tages, including biodegradability, easy processing, mini-
mally invasive delivery manner, and modulating ability by
regulation of crosslink density. For these reasons, hydrogels
have been widely used in TE application and especially in
CTE.79 COL is one of the most common ECM derivatives
used for culturing cells in vitro. COL can be reconstructed to
form hydrogel to mimic the connective tissue in vitro. Nu-
merous ECM-like composites that combine 3D COL hy-
drogels with synthetic and natural polymers have been
examined.76 Hybrid gel matrices composed of COL and
CHSN had been examined for their capacity to regulate
cellular activity. The K562 (a human hematopoietic cell
line) cells were cultured in 3D gels to examine cell prolif-
eration and differentiation.76 In completion of the previous
studies, elastic cryogels composed of CHSN–GEL were
prepared via crosslinking with glutaraldehyde. Hybrid
cryogels exhibited efficient cell adherence, proliferation,
and ECM deposition by culturing a fibroblast cell line (Cos-
7). The results showed the potential of the hybrid hydrogel
for TE applications.73 To achieve proper biomechanical and
biological properties, researchers tried to fabricate scaffolds
based on an optimized ratio of polymer solutions (CHSN,
FIG. 1. (A, B) Nanofiber composites of PVA-MA and CS-MA were synthesized using electrospinning system in which the
nanofibers were collected into an ethanol bath. (C) In vitro chondrogenesis of MSCs was performed over 42 days. (D) Nanofibers
were implanted into osteochondral defects in the rat hind limbs for 6 weeks. (E) Scanning electron microscopy imaging showed
the morphology and (F) size distribution of the fibers.165 CS, chondroitin sulfate; MA, methacrylamide; MSCs, mesenchymal
stromal cells; PVA, poly vinyl alcohol. Reprinted with permission from Coburn et al.165 Color images are available online.
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Aga, and GEL) and glutaraldehyde as the crosslinker, via
cryogelation technology with incubation at subzero tem-
perature. The fabricated scaffolds showed proper biodegra-
dation, mechanical, and biological properties for effective
cell interaction in subsequent tissue development. In vivo
biocompatibility examination of the scaffolds suggested the
potential of these cryogels as a 3D scaffold for CTE.166
Human chondrocytes were encapsulated in GEL-MA-based
hydrogels, and combined with small amounts of photo-
crosslinkable CS-MA and HA-MA. According to the results,
the incorporation of HA-MA to GEL-MA resulted in further
round cell morphologies, improved chondrogenesis, and
increased synthesized neomatrix throughout the hydrogel.
As a result, the compressive modulus of the hydrogel con-
taining HA-MA and CS-MA increased to 114 kPa compared
with the control GEL-MA (26 kPa) after 8 weeks of culture.105
Entrapment of ECM molecules within a synthetic hy-
drogel is ultimately the most comprehensive method to
create hydrogels containing biological signals. The ultra
violet (UV) photopolymerized PVA hydrogels were prepared
via methacrylated functionalization, and the effects of in-
corporation of heparin and GEL within a PVA hydrogel were
examined.167 Chen et al. advanced the novel double network
PEG/COL, whose mechanical strength could be modified by
changing the rigidity, molecular weight, and crosslinking
density of the two components. Results indicated that the
incorporation of COL significantly enhanced the strength and
toughness of hydrogels. The resulting hydrogels could offer a
proper environment for cell attachment and proliferation.38
Injectable hydrogels can be presented by minimally invasive
procedures and activated by environmental conditions, in-
cluding pH, temperature, ultrasound, ionic strength, or electric
fields, to undertake a shape compliant to the surrounding defect
site. Moreover, biological cues such as cells and growth factors
could be coinjected with the hydrogels.80 Injectable synthetic/
natural hydrogel composites containing oligo(PEG)-fumarate
(OPF), and GEL microparticles (GMP), were synthesized.
OPF/GMP TGF-b1-loaded composites, hydrogel encapsulat-
ing rabbit MSCs, supported osteochondral tissue generation in
rabbit osteochondral defects at 12 weeks.72 Novel biodegrad-
able, biocompatible, and tough elastomeric hybrid hydrogels
based on photocrosslinkable GEL and ionically crosslinkable
ALG were engineered. These hydrogels offer an exciting ve-
nue to investigate the effect of mechanical stimulation on SC
proliferation and differentiation.46 In situ CS/GEL hydro-
gels were achieved by simple mixing of aqueous solutions
of both GEL–tris(carboxyethyl)phosphine and CS–ac-
rylate via click chemistry strategy. In vitro studies
showed excellent biocompatibility and potential of the
hydrogel in various biomedical applications, including TE
and drug delivery.131
Various ECM derivative molecules, such as CS and HA,
have been used as the 3D hydrogels to support SC chon-
drogenesis. However, because of the lack of proper me-
chanical properties and matrix stiffness, it is difficult to
explain the relative contribution of matrix stiffness on SC
fate using ECM derivative hydrogels. Improvement of me-
chanical properties of these hydrogels can occur by incor-
poration of polymeric biomaterials.106 Three major types of
cartilage ECM derivatives, HA, CS, and heparan sulfate,
were incorporated to fabricate biomimetic hybrid scaffolds.
The degree of methacrylation of these ECM molecules was
a key factor to produce ECM-based hydrogel scaffolds. To
investigate the effects of mechanical and biochemical cues
on chondrogenesis, ADSCs were encapsulated in differ-
ent hydrogel compositions with various ECM derivative
concentrations [0.5%, 1.25%, 2.5%, and 5% (w/v)] and
different matrix stiffnesses (3, 30, and 90 kPa). The results
indicated that the influence of matrix stiffness on chon-
drogenesis is dependent on the composition of hydrogels in
a nonlinear manner.106 A chondrogenic hydrogel com-
posed of fibrin/HA-MA seeded with MSCs was further
evaluated. The results indicated that the hydrogel could be
considered a proper vehicle for MSC delivery and chon-
drogenesis induction.103
Regarding the disadvantage of using crosslinking agents
in biological systems, a novel biocompatible hybrid hydro-
gel was prepared by an oxidized HA/CHSN solution in the
absence of a crosslinker. This composite hydrogel supported
the survival of encapsulated bovine articular chondrocytes,
which retained a chondrocytic morphology.116 Novel in-
jectable mixtures were synthesized under physiological
conditions with PEG vinylsulfone macromers and thiol
functionalized HA, which were crosslinked via Michael
addition. On mixing with chondrocytes, these hydrogels
afforded a homogeneous distribution of cells.113 Another
injectable hydrogel, using blending of thermoresponsive
engineered proteins and a dynamic covalent crosslinking
system, was fabricated. By mixing aldehyde-modified HA
and hydrazine-modified elastin-like protein via dynamic
covalent hydrazone bonds, hydrogel formation occurred.
This hydrogel represented proper mechanical support to
encapsulated human mesenchymal stromal cells (hMSCs)
during injection.91 In a recently published study by Raia
et al.,94 HA and SF were enzymatically crosslinked to
fabricate biocompatible hydrogels with mechanical strength
comparable with the native tissues. The SF proteins cross-
linked via horseradish peroxidase (HRP) by formation of di-
tyrosine bonds, and tyramine (TA)-substituted HA was
synthesized by the same reactions. Consequently, HA was
covalently crosslinked with silk to form a composite hydrogel
(Fig. 2). The results show that synthesized hydrogel can pro-
vide a proper biologically system with controllable mechanical
properties for TE applications.94 According to previous works,
HA-MA with different degrees of methacrylation were
synthesized. The degree of methacrylation modulated ma-
trix stiffness of the hydrogels, therefore affecting the ability
of hADSC chondrogenesis.83
PVA is one of the most studied polymers in biomedical
application, because of its great biocompatibility in com-
bination with a variety of appropriate biomechanical prop-
erties, swelling capacity, and crosslinking opportunities.
Nanda et al.126 crosslinked the PVA-CS hydrogels with
glutaraldehyde and used them as a scaffold in TE.144 Also,
hydrogel scaffolds of PVA/CS were fabricated to imitate the
ECM to provide an environment for improved AC cartilage
repair in vivo.126 Recently, based on CS, enzymatically
crosslinkable, injectable, minimally invasive, and biode-
gradable hydrogels have been described under physiological
conditions. The hydrogels consisted of carboxymethyl
pullulan-TA (CMP-TA) and CS-TA conjugates, which were
enzymatically crosslinked by horseradish peroxidase and
hydrogen peroxide. According to the results, hydrogels were
cytocompatible. The CMP-TA/CS-TA composite hydrogels
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enhanced cartilaginous ECM synthesis and cell chon-
drogenesis.138 Injectable and self-crosslinkable hydrogels
were fabricated based on COL I and activated CS with N-
hydroxysuccinimide by chemical and physical crosslinking
without catalysts. The results suggest that these hydrogels
were suitable candidates for applications in the fields of cell
delivery and TE.37
Synthetic and natural compounds can be used to produce
hydrogels taking advantage of their complementary and
sometimes synergistic properties. Hydrogels consisting of
ECM analogs can be similar to the natural cartilaginous
ECM. Through the elastic network, they facilitate transport
of nutrients and cellular metabolites, and they can be applied
by simple, minimally invasive procedures to fill large and
irregular complex defects.138,147 Similarly, injectable hy-
drogel based on methacrylated solubilized decellularized
porcine cartilage was prepared by methacrylation and UV
photocrosslinking modifications. In vitro studies showed
that these hydrogels induced chondrogenic gene expression
and new ECM cartilage formation with mechanical char-
acteristics of native cartilage.147 In conclusion, hydrogels
can be prepared from both synthetic and natural biomate-
rials. Synthetic biomaterials have the ability to control the
chemical composition, mechanical properties, and biodeg-
radation rate of the composite hydrogels. In contrast, hy-
drogels composed of natural biomaterials have the ability of
providing biological cues and signals to enhance cell ad-
hesion, proliferation, and differentiation. However, hybrid
hydrogels composed of both synthetic/natural biomaterials
can be an effective tool to achieve optimal cartilage re-
generation.
3D printing and biofabrication
Additive manufacturing tools are based on the develop-
ment of computer science and manufacturing technologies.
The potential to fabricate highly complex constructs such
as whole organs directly from a computer model is one
of the main advantages of these approaches.168 Additive
manufacturing offers a different potential to understand the
structural constraints for TE scaffolds. On the contrary, it is
also critical to develop the methods allowing efficient
scaffold cellularization independent of shape and porosi-
ty.169 Frequently due to the absence of biological cues and
hydrophobicity of the synthetic biomaterials used in scaffold
fabrication by additive manufacturing, these scaffolds gen-
erally offer a limited environment for cell attachment and
growth. Conversely, in those biofabrication techniques using
living cells and biological materials, tissues are directly
produced with ECM derivatives by controlling their 3D
structures. However, inferior mechanical properties of such
biofabricated constructs are considered a main limitation of
these approaches.170 Recently, to overcome these restric-
tions, multihead deposition systems with the ability of bio-
printing different row constituents consisting of synthetic
and natural biomaterials, proteins, and cells have been de-
veloped.171 Xu et al.62 tried to use inkjet-based cell printing
in conjunction with electrospinning to fabricate constructs
with improved mechanical properties. After spinning of a
PCL layer, a rabbit chondrocyte/fibrinogen/COL solution
was deposited onto the electrospun PCL fibrous layer. After
gelation of the cell-printed solution, PCL was spun another
time and followed by inkjet cell printing again. A final
construct consisting of five layers of 1 mm thickness was
fabricated. Cells showed >80% viability a week after cul-
ture.62 Before using GEL-MA as a biomaterial for biofab-
rication purposes, several crosslinking parameters consisting
of UV exposure time, polymer concentration, and thermal
gelation before UV exposure were investigated to control
the swelling and mechanical properties of the hydrogel. The
opportunity to control mechanical properties, swelling be-
havior, and high cell compatibility and the ability to syn-
thesize cartilaginous matrix make GEL-MA a suitable
material for CTE. Results showed that when GEL-MA is
combined with HA as a viscosity-enhancing additive, it could
be printed into layered hydrogel structures. The results
FIG. 2. (a) The silk-HA
gel formation by covalent
crosslinking of tyramine side
chains on HA and tyrosine
residues on silk. (b) The im-
ages of silk-HA gelation
through a vial inversion test.
(c) Vial inversion test results
to evaluate gelation times.
(d) The increasing of HA
concentration affected
crosslinking kinetics (n = 7).94
(n = 4, ***p < 0.001). Rep-
rinted from Biomaterials, Raia
et al.,131 Enzymatically cross-
linked silk-hyaluronic acid
hydrogels, pp, 58–67, 2017,
with permission from Elsevier.
HA, hyaluronic acid; H2O2,
hydrogen peroxide. Color
images are available online.
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confirmed that the engineered constructs allow matching the
natural functional variations in cartilage biomechanical
properties.107 In a more recent approach, Visser et al.172 re-
inforced soft GEL-MA hydrogels with high porosity and a
highly organized 3D-printed PCL network that was fabricated
via the MEW technique. The mechanical properties of the
gel/scaffold composites improved compared with microfiber
scaffolds or hydrogels alone. Chondrocytes embedded in the
hybrid construct were viable, and retained their round mor-
phology and physiological behavior in vitro.172 A novel hy-
brid scaffold based on PLA/photopolymerizable cell-laden
hydrogels has been established. A hydrogel precursor was
prepared from a solution of MA-modified GEL and the
photoinitiator Li-TPO-L in cell culture medium. The fabri-
cated TE constructs merged both advantages, synthetic ad-
ditive manufactured constructs and a natural hydrogel
matrix.169 Recently, a bioink consisting of GEL-MA, CS-
amino ethyl-MA, and HA-MA was loaded with MSCs to
fabricate 3D biomimetic hydrogel scaffolds for CTE. Two
coaxial needles were used to establish a proper system to
bioprint hybrid constructs with high cell viability, high cell
density, and high bioprinting resolution. The results con-
firmed that this method is a valuable candidate for advanced
CTE.139 By combining SF and GEL with MSCs and a
specific-affinity peptide E7, a functionally and structurally
improved scaffold was designed via an indirect 3D printing
method. Briefly, The SF-GEL mixture solution was dispensed
to a 3D computer-aided design mold. After decreasing the
temperature to form the gel, the mold was dissolved, and the
scaffold then crosslinked with genipin. The scaffold showed
efficient recruiting capacity for MSCs and provided a me-
chanical support and proper microenvironment for prolifera-
tion, differentiation, and neocartilage tissue production.49
Fabrication of gradient structures has been made by using the
layer-by-layer inherent fabrication of additive manufacturing
technologies. Gradient functionalization with controlled ge-
ometry and porosity on the surface of an additive manu-
factured PCL scaffold was investigated. First, the surface of
PCL scaffold was aminolysed using a continuous gradient of
amine concentration; second, by using EDC reaction, a COL
gradient was formed via protein grafting. The results showed
that for the construction of 3D scaffolds with chemical
gradients and controlled structural properties, a combi-
nation of surface modification and additive manufacturing
is an appealing strategy.45 A tabletop stereolithography-
based bioprinter has been used for a new cell-laden
CT construct fabrication. The bioink was composed
of GEL-MA, various concentrations of PEG diacrylate, 2-
hydroxy-4-(2-hydroxyethoxy)-2-methylpropiophenone as
a photoinitiator, and TGF-b1-embedded nanospheres
(Fig. 3). Cell growth, viability, and chondrogenesis were
explored to develop an optimized 3D-bioprinted construct
for CTE. A significant increase in chondrocyte-specific gene
expression on printed constructs containing TGF-b1 nano-
spheres over 3 weeks showed that cell-laden bioprinting is a
promising strategy for CTE.32 A bioprintable natural bioink
based on cartilage acellular matrix (CAM) for bioprinting of
irregular shape tissues has been developed. As a support of
the CAM powder, SF was used because of its physical
crosslinking ability and controllable viscosity. Bioprinting of
a cartilage-shaped scaffold using this CAM-SF bioink has
been done successfully.151 The results of in vitro culture
showed that a printed CAM-SF construct provided better cell
morphology and neomatrix synthesis from rabbit BMSCs
compared with a printed PCL construct.
According to recently published articles, bioprinting ap-
proaches have shown great potential in CTE applications.
However, several limitations are still remaining in achieving
FIG. 3. Schematic design of cartilage construct printing via stereolithography-based bioprinter and synthesized bioink.32
GEL-MA, gelatin-methacrylamide; PEGDA, poly ethylene glycol diacrylate; PLGA, poly(DL-lactic-co-glycolic acid);
TGF-b1, transforming growth factor-beta 1; UV, ultra violet. Color images are available online.
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clinical applicability of these methods. The most challenging
limitations are technical improvement and standardization,
bioink formulation, and more closely mimicking the native
cartilage mechanical properties.151 However, when different
synthetic and natural biomaterials are associated within
bioinks, they appear to mimic the cartilage microenvironment
and to enhance cell viability and chondrogenic ability.
Freeze-drying
In FD, the material is frozen in a hydrogel shape and the
water forms pockets of ice throughout the matrix. Conse-
quently, these ice pockets are sublimated and removed un-
der vacuum to produce the porous network. The size of
pores can be controlled by the freezing temperature, thus
producing porous structures with varying pore sizes and
interconnectivities, due to varying heat transfer coefficients.
Interconnected network composite scaffolds based on in-
corporating type II COL with CS and HA were fabricated
utilizing chemical crosslinking and FD procedures, to mimic
the native ECM of AC and upregulate cartilage ECM bio-
synthetic activities.74 The 3D porous hybrid scaffolds were
prepared with incorporation of PLGA microspheres into
GEL/CHSN/HA scaffolds and crosslinking with EDC, using
the simple FD method. Cell culture confirmed that chon-
drocytes could secrete ECM and proliferate similar to the
control (GEL/CHSN/HA scaffolds).117 The FD method was
also used to prepare interconnected PVA/GEL/nanohy-
droxyapatite/polyamide-6 bilayered hybrid scaffolds for in
situ osteochondral defect repair.68 In another study, COL/
PLA, CHSN/PLA, and COL/CHSN/PLA hybrid scaffolds
were fabricated via the combination of FD of the natural
biomaterials COL and CHSN and PLA meshes. The 3D
PLA meshes provided mechanical properties and the natural
biomaterials mimicked the natural niche of chondrocytes.59
GEL scaffolds with interconnected pore structures and with
good mechanical strength were fabricated using ice partic-
ulates and FD. Bovine articular chondrocytes were cultured
on these scaffolds, for CT formation in vitro.173 The 3D
porous scaffold-based cellulose nanofibers, stabilized using
a genipin crosslinked matrix of Gel and CHSN, were pre-
pared using FD. The results showed that the scaffolds have
interconnected and homogenous pores, which supported
chondrogenesis, thus highlighting the impact and efficiency
of FD in the fabrication of hybrid scaffolds for CTE appli-
cation of CHSN.53 Open and interconnected pore structures
are considered the most important characteristic of the TE
scaffolds.35 Uniform multidirectional COL-based scaffolds
were fabricated by unidirectional freeze casting of COL/HA
and COL/hydroxyapatite suspensions. The scaffolds were
joined by a lyophilization bonding process. With the ar-
rangement of these compositional and architectural biomi-
metic cues, the scaffolds hold great capacity for zonal
CTE.43 A novel class of hybrid scaffolds based on CHSN as
a structural material and low portion of HA to mimic car-
tilage ECM were fabricated using FD. The results showed
that incorporation of HA to the CHSN scaffolds enhanced
the biological properties of the scaffolds, which had a su-
perior porous structure network and exhibited higher carti-
lage ECM deposition.109 To fabricate porous hybrid
constructs, CS was blended with SF to fabricate SF/CS
scaffolds via FD. The scaffolds showed a pore size of 37–
212mm, contact angle 46.2–50.38, biodegradation, and
controlled swelling. Biocompatibility was confirmed by im-
plantation of scaffolds subcutaneously in a mouse. The results
indicated that incorporation of CS to the scaffolds promoted
proliferation, cell attachment, and metabolic activity of
hMSCs in vitro.130 Despite the great advantage of using the
FD technique in fabrication of hybrid constructs in CTE, a
small and nonhomogeneous pore size can be considered the
main limitation of this method for several materials.
Solvent casting and particulate leaching techniques
In particulate leaching (PL) techniques, pore size and
porosity of the scaffolds can be controlled by a selection of
appropriate porogen materials. Using this method, numerous
porous structures have been fabricated from varied synthetic
and natural biomaterials for TE applications.79 Electro-
spinning combined with salt leaching (SL) has also been
used to fabricate macroporous and nanofibrous HA scaf-
folds. HA and COL were electrospun into a nanofiber mesh
by the deposition of salt particles during electrospinning and
following crosslinking and SL. Cytocompatibility of the
scaffold was evaluated by culturing bovine chondrocytes on
the HA/COL scaffolds. The results demonstrated that cell
proliferation was improved and COL content enhanced.122
Gas foaming/SL was used for the fabrication of PLGA/HA
hybrid scaffolds. The PLGA scaffolds were fabricated by
blending PLGA with varying amounts of amine-terminated
PLGA-PEG diblock copolymers. Gene expression results,
biochemical assays, and histological analysis showed that
HA-modified scaffolds supported higher cartilage ECM
formation, COL II gene expression, and morphological
characteristics.174 Porous scaffolds based on poly(3-
hydroxybutyrate-co-3-hydroxyhexanoate) tubes were fab-
ricated using a dipping method followed by SL. Culture of
hMSCs on hybrid scaffolds showed early chondrogenic
differentiation by expression of SOX9 in the presence of a
proper induction medium.60 Nanocomposite scaffolds
composed of PLGA/HA/fibrin/bioglass were prepared us-
ing solvent casting and PL (SC-PL) techniques. The scaf-
folds showed proper porosity percentage (87.01 – 3%) with
interconnected pore morphologies and pore size between
100 and 200 mm. The nanocomposite scaffold was cyto-
compatible, and the human adipose tissue-derived mesen-
chymal stem cells attached and proliferated on the scaffold.
These scaffolds can be used for CTE applications.102 To
overcome the possible disadvantages of PLGA, such as its
hydrophobicity, limited support of nutrient exchange, and
induction of inflammatory responses, micronized porcine
cartilage (MPC) was added to the scaffolds to reduce the
inflammatory effects and improve cell attachment and pro-
liferation. PLGA and MPC/PLGA scaffolds were fabricated
by the SC-PL technique. The results showed that incorpora-
tion of bioactive materials of MPC had constructive effects
for enhancing PLGA scaffold biocompatibility.149
Future Outlook
About 132 articles published between 2000 and 2018,
describing ECM-based hybrid and composite scaffolds used
in CTE, were reviewed in the present study (Tables 1–4).
A statistical analysis demonstrates which materials and
methods are the most frequently used for ECM-based
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hybrid scaffold fabrication. To evaluate frequency of the
different materials and methods, the number of published
articles for each material or method was divided by total
number of published articles during these years [frequency
percentage = (number of published articles for each ma-
terials or methods/total number of published articles) ·100].
The results indicated that between cartilage ECM deriva-
tives, the most frequently used materials were COL (40%),
HA (34%), CS (14%), and cECMa (12%). According to
the results, the most used synthetic materials to design
hybrid and composite scaffolds in CTE are PLGA (18%),
MA (16%), PCL (15%), PEG (9%), PVA (9%), and PLA
(8%), and other polymeric materials consisting of poly-N-
(vinylcaprolactam), other polyesters, polyurethanes, and
PGA (25% totally). Among natural biomaterials, CHSN
(41%), SF (21%), ALG (14%), fibrin (11%), and AGR
(5%), respectively, were the most frequently used in CTE.
Finally, among scaffolding methods for fabrication of
hybrid scaffolds at CTE applications, hydrogels (38%),
fibrous scaffolds (22%), FD (15%), 3D printing (10%), SC-
PL (6%), and other methods consisting of the microsphere,
mesh-microsponge, fiber–hydrogel (9% totally) were more
familiar, respectively. COL and HA have been mostly used
in the fabrication of hybrid scaffolds in comparison with
other ECM derivatives. These two polymers have been
thoroughly investigated because of their biocompatibility,
biomimetic properties, and abundance. As shown in the
beginning, synthetic polymers, PLGA, PCL, and MA, were
more frequently used hybrid scaffolds than PVA, PLA, and
PEG polymers. PLGA and PCL are biodegradable, biocom-
patible, and their rate of biodegradation can be controlled by
the degree of hybridization with other synthetic and natural
biomaterials. Results demonstrated that CHSN has been used
the most frequently as a natural biomaterial in the fabrica-
tion of hybrid scaffolds. CHSN biostability is due to its large
number of reactive amino groups that play a useful role as
sites for specific crosslinking. CHSN is miscible at the mo-
lecular level and it exhibits hydrogen bonding or electrostatic
interactions that contribute to mechanical stability. Further-
more, adding CHSN to ECM derivatives increases the number
of crosslinking sites. When crosslinked, these hybrid scaffolds
prevent access to hydrolytic enzymes to the sensitive cleavage
sites of ECM derivatives. Biostability on the one hand and
degradation rates on the other hand can be controlled by
the extent and type of crosslinking. Finally, among the fab-
rication methods, hydrogels and fibrous approaches were the
most common in CTE application.
As the results show, collagens and HA were used most
frequently in the fabrication of hybrid scaffolds. However,
according to articles published in recent years, the use of
ECM analogs in the preparation of hybrid scaffolds for CTE
applications has been expanding due to the potential to in-
duce SC differentiation.
Among natural biomaterials, CHSN has been widely used
due to its miscibility with ECM derivatives, and the pres-
ence of functional groups for crosslinking with ECM de-
rivatives, all important features for cartilage tissue repair.
With regard to fabrication, hydrogels and fibers are used
most frequently in hybrid scaffold fabrication due to their
similarity to natural cartilage structure. There is also a growing
trend with the use of injectable hydrogels and biofabrication
methods for CTE.
Conclusions
In hybrid scaffold fabrication, ECM-derived biomole-
cules are combined with natural or synthetic biomaterials.
Because of their specific biophysical and biochemical
properties, hybrid scaffolds provide superior interactions
with cells and better control of cell adhesion, spreading,
proliferation, and differentiation. ECM-derived hybrid
scaffolds are promising materials for cartilage and other TE
needs. Hybrid scaffolds consisting of cell-derived ECM and
synthetic materials have superior mechanical properties
compared with acellular tissues and pure ECM scaffolds.
Based on the reviewed publications, it is possible to con-
clude that COL and HA are the most frequently used in
hybrid scaffolds for CTE, and that from the perspective of
fabrication or process or material format, fibrous and hy-
drogel scaffolds are the most popular.
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